XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating expenses        
Research and development $ 7,931 $ 7,452 $ 23,245 $ 19,830
General and administrative 3,267 3,146 9,417 9,910
Total operating expenses 11,198 10,598 32,662 29,740
Loss from operations (11,198) (10,598) (32,662) (29,740)
Other income, net 849 127 1,962 158
Net loss and comprehensive loss $ (10,349) $ (10,471) $ (30,700) $ (29,582)
Net loss per share, Basic $ (0.35) $ (0.73) $ (1.35) $ (2.07)
Net loss per share, Diluted $ (0.35) $ (0.73) $ (1.35) $ (2.07)
Weighted-average common shares outstanding, Basic 29,974,400 14,265,905 22,813,085 14,289,729
Weighted Average Number of Shares Outstanding, Diluted 29,974,400 14,265,905 22,813,085 14,289,729